196 related articles for article (PubMed ID: 22391565)
1. Low dose IR-induced IGF-1-sCLU expression: a p53-repressed expression cascade that interferes with TGFβ1 signaling to confer a pro-survival bystander effect.
Klokov D; Leskov K; Araki S; Zou Y; Goetz EM; Luo X; Willson D; Boothman DA
Oncogene; 2013 Jan; 32(4):479-90. PubMed ID: 22391565
[TBL] [Abstract][Full Text] [Related]
2. IR-inducible clusterin gene expression: a protein with potential roles in ionizing radiation-induced adaptive responses, genomic instability, and bystander effects.
Klokov D; Criswell T; Leskov KS; Araki S; Mayo L; Boothman DA
Mutat Res; 2004 Dec; 568(1):97-110. PubMed ID: 15530543
[TBL] [Abstract][Full Text] [Related]
3. Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein.
Criswell T; Klokov D; Beman M; Lavik JP; Boothman DA
Cancer Biol Ther; 2003; 2(4):372-80. PubMed ID: 14508108
[TBL] [Abstract][Full Text] [Related]
4. ATM-dependent IGF-1 induction regulates secretory clusterin expression after DNA damage and in genetic instability.
Goetz EM; Shankar B; Zou Y; Morales JC; Luo X; Araki S; Bachoo R; Mayo LD; Boothman DA
Oncogene; 2011 Sep; 30(35):3745-54. PubMed ID: 21460853
[TBL] [Abstract][Full Text] [Related]
5. Clusterin confers resistance to TNF-alpha-induced apoptosis in breast cancer cells through NF-kappaB activation and Bcl-2 overexpression.
Wang Y; Wang X; Zhao H; Liang B; Du Q
J Chemother; 2012 Dec; 24(6):348-57. PubMed ID: 23174100
[TBL] [Abstract][Full Text] [Related]
6. Delayed activation of insulin-like growth factor-1 receptor/Src/MAPK/Egr-1 signaling regulates clusterin expression, a pro-survival factor.
Criswell T; Beman M; Araki S; Leskov K; Cataldo E; Mayo LD; Boothman DA
J Biol Chem; 2005 Apr; 280(14):14212-21. PubMed ID: 15689620
[TBL] [Abstract][Full Text] [Related]
7. ATM regulates insulin-like growth factor 1-secretory clusterin (IGF-1-sCLU) expression that protects cells against senescence.
Luo X; Suzuki M; Ghandhi SA; Amundson SA; Boothman DA
PLoS One; 2014; 9(6):e99983. PubMed ID: 24937130
[TBL] [Abstract][Full Text] [Related]
8. IGF-1 activates the P13K/AKT signaling pathway via upregulation of secretory clusterin.
Ma X; Bai Y
Mol Med Rep; 2012 Dec; 6(6):1433-7. PubMed ID: 23027041
[TBL] [Abstract][Full Text] [Related]
9. CRM1 protein-mediated regulation of nuclear clusterin (nCLU), an ionizing radiation-stimulated, Bax-dependent pro-death factor.
Leskov KS; Araki S; Lavik JP; Gomez JA; Gama V; Gonos ES; Trougakos IP; Matsuyama S; Boothman DA
J Biol Chem; 2011 Nov; 286(46):40083-90. PubMed ID: 21953454
[TBL] [Abstract][Full Text] [Related]
10. Clusterin, a Novel DEC1 Target, Modulates DNA Damage-Mediated Cell Death.
Ming X; Bao C; Hong T; Yang Y; Chen X; Jung YS; Qian Y
Mol Cancer Res; 2018 Nov; 16(11):1641-1651. PubMed ID: 30002194
[TBL] [Abstract][Full Text] [Related]
11. Secretory clusterin promotes oral cancer cell survival via inhibiting apoptosis by activation of autophagy in AMPK/mTOR/ULK1 dependent pathway.
Naik PP; Mukhopadhyay S; Praharaj PP; Bhol CS; Panigrahi DP; Mahapatra KK; Patra S; Saha S; Panda AK; Panda K; Paul S; Aich P; Patra SK; Bhutia SK
Life Sci; 2021 Jan; 264():118722. PubMed ID: 33160989
[TBL] [Abstract][Full Text] [Related]
12. The chaperone activity of clusterin is dependent on glycosylation and redox environment.
Rohne P; Prochnow H; Wolf S; Renner B; Koch-Brandt C
Cell Physiol Biochem; 2014; 34(5):1626-39. PubMed ID: 25402950
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-I induces CLU expression through Twist1 to promote prostate cancer growth.
Takeuchi A; Shiota M; Beraldi E; Thaper D; Takahara K; Ibuki N; Pollak M; Cox ME; Naito S; Gleave ME; Zoubeidi A
Mol Cell Endocrinol; 2014 Mar; 384(1-2):117-25. PubMed ID: 24491388
[TBL] [Abstract][Full Text] [Related]
14. Coordinate transcriptional and translational repression of p53 by TGF-β1 impairs the stress response.
López-Díaz FJ; Gascard P; Balakrishnan SK; Zhao J; Del Rincon SV; Spruck C; Tlsty TD; Emerson BM
Mol Cell; 2013 May; 50(4):552-64. PubMed ID: 23706820
[TBL] [Abstract][Full Text] [Related]
15. Small interfering RNA targeted to secretory clusterin blocks tumor growth, motility, and invasion in breast cancer.
Niu Z; Li X; Hu B; Li R; Wang L; Wu L; Wang X
Acta Biochim Biophys Sin (Shanghai); 2012 Dec; 44(12):991-8. PubMed ID: 23099883
[TBL] [Abstract][Full Text] [Related]
16. mda-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancer.
Bhutia SK; Das SK; Kegelman TP; Azab B; Dash R; Su ZZ; Wang XY; Rizzi F; Bettuzzi S; Lee SG; Dent P; Grant S; Curiel DT; Sarkar D; Fisher PB
J Cell Physiol; 2012 May; 227(5):1805-13. PubMed ID: 21732348
[TBL] [Abstract][Full Text] [Related]
17. Tumor-derived secretory clusterin induces epithelial-mesenchymal transition and facilitates hepatocellular carcinoma metastasis.
Wang C; Jiang K; Kang X; Gao D; Sun C; Li Y; Sun L; Zhang S; Liu X; Wu W; Yang P; Guo K; Liu Y
Int J Biochem Cell Biol; 2012 Dec; 44(12):2308-20. PubMed ID: 23010347
[TBL] [Abstract][Full Text] [Related]
18. eIF3f reduces tumor growth by directly interrupting clusterin with anti-apoptotic property in cancer cells.
Lee JY; Kim HJ; Rho SB; Lee SH
Oncotarget; 2016 Apr; 7(14):18541-57. PubMed ID: 26988917
[TBL] [Abstract][Full Text] [Related]
19. siRNA-directed clusterin silencing promotes cisplatin antitumor activity in human non-small cell lung cancer xenografts in immunodeficient mice.
Zhang B; Liu ZM; Hao FG; Wang M
Eur Rev Med Pharmacol Sci; 2014 Jun; 18(11):1595-601. PubMed ID: 24943969
[TBL] [Abstract][Full Text] [Related]
20. Induction of clusterin by AKT--role in cytoprotection against docetaxel in prostate tumor cells.
Zhong B; Sallman DA; Gilvary DL; Pernazza D; Sahakian E; Fritz D; Cheng JQ; Trougakos I; Wei S; Djeu JY
Mol Cancer Ther; 2010 Jun; 9(6):1831-41. PubMed ID: 20501799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
